Investments in and Advances to Unconsolidated Joint Ventures (Tables)

12 Months Ended

Dec. 31, 2016

Investments in and Advances to Unconsolidated Joint Ventures

Company owned interests in entities, accounted under equity method (dollars in thousands)

The Company owns interests in the following entities that are accounted for under the equity method (dollars in thousands):

			Carrying Amount
			December 31,
Entity(1)	Segment	Ownership %	2016		2015
CCRC JV(2)	SHOP	49	$	439,449		$	465,179
MBK JV(3)	SHOP	50		38,909			34,131
HCP Ventures III, LLC	Medical office	30		1,533			9,241
HCP Ventures IV, LLC	Medical office	20		7,277			11,884
HCP Life Science(4)	Life science	50-63		67,879			68,582
Vintage Park	SHOP	85		7,486			8,729
MBK Development JV(3)	SHOP	50		2,463			2,224
Suburban Properties, LLC	Medical office	67		4,628			4,621
K&Y(5)	Other	80		1,342			—
Advances to unconsolidated joint ventures, net and other				525			653
			$	571,491		$	605,244

(1) These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures.

(2) Includes two unconsolidated joint ventures in a RIDEA structure (CCRC PropCo and CCRC OpCo).

(3) Includes two unconsolidated joint ventures in a RIDEA structure (PropCo and OpCo).

(4) Includes three unconsolidated joint ventures between the Company and an institutional capital partner for which the Company is the managing member. HCP Life Science includes the following partnerships (and the Company’s ownership percentage): (i) Torrey Pines Science Center, LP (50%); (ii) Britannia Biotech Gateway, LP (55%); and (iii) LASDK, LP (63%).

(5) Includes three unconsolidated joint ventures.